Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma
Why Patients Skip Doses: Medisafe Annual Adherence Index
Can Celgene's latest Revlimid win turn the bad-news tide?
Tuesday, July 24, 2018
Celgene ended a losing streak Monday with a Revlimid trial win, and one analyst thinks more rosy pipeline events could follow soon.
Evaluation of Analytics in Health Plans Today
BMS, AbbVie eye new Empliciti use after phase 2 combo win
Monday, June 18, 2018
With impressive new survival data in hand, Bristol-Myers Squibb and AbbVie could land a new indication for Empliciti.
FiercePharmaAsia—China’s data rule, Biocon-Mylan and more
Friday, June 8, 2018
Experts say China's data sharing rule may hinder drug R&D; FDA rejects Mylan and Biocon's Lantus biosim and more news.
AstraZeneca's Fasenra fails second COPD trial
Wednesday, May 30, 2018
AstraZeneca’s hopes for expanding severe asthma drug Fasenra into COPD are officially lost.
The Changing Landscape of Real-World Evidence and its Impact on Clinical Research
Handling Suspected Fraud and Data Fabrication in Clinical Studies
SEC eyes civil charges against Clovis over ditched cancer drug
Wednesday, April 11, 2018
Just three days after celebrating a new FDA approval for use of its cancer drug Rubraca, Clovis Oncology quietly disclosed bad news about a saga that dates back two years.